These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 608505

  • 1. Cell mediated immunity to Corynebacterium parvum and its role in tumor control.
    Tuttle RL.
    Dev Biol Stand; ; 38():189-93. PubMed ID: 608505
    [Abstract] [Full Text] [Related]

  • 2. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K, Miwa H, Hashimoto O, Inoue T, Orita K.
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of resistance to Listeria monocytogenes enhanced by Corynebacterium parvum in mice.
    Miyata H, Nomoto K, Takeya K.
    Immunology; 1980 May; 40(1):33-9. PubMed ID: 6968291
    [Abstract] [Full Text] [Related]

  • 4. In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice.
    Lagrange PH, Thickstun PM.
    J Natl Cancer Inst; 1979 Feb; 62(2):429-36. PubMed ID: 283275
    [Abstract] [Full Text] [Related]

  • 5. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
    Halpern B, Gauthier-Rahman S, Besluau D.
    C R Seances Soc Biol Fil; 1977 Feb; 171(6):1202-8. PubMed ID: 148948
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
    Gauthier-Rahman S.
    Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H, Himeno K, Nomoto K.
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [Abstract] [Full Text] [Related]

  • 8. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV.
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [Abstract] [Full Text] [Related]

  • 9. C. parvum skin testing antigen: study on guinea pig model.
    Roumiantzeff M, Colombet G.
    Dev Biol Stand; 1975 Jun; 38():65-72. PubMed ID: 608551
    [Abstract] [Full Text] [Related]

  • 10. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J, Mara M.
    Neoplasma; 1987 Jun; 34(1):15-22. PubMed ID: 3031518
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of antitumor action of Corynebacterium parvum: the generation of cell-mediated tumor specific immunity.
    Tuttle RL, North RJ.
    J Reticuloendothel Soc; 1976 Sep; 20(3):197-208. PubMed ID: 978659
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of Corynebacterium parvum on the immune response in guinea pigs. II. Passive transfer of enhanced anamnestic response and delayed hypersensitivity observed after treatment with Corynebacterium parvum].
    Halpern B, Gauthier-Rahman S, Besluau D.
    C R Seances Soc Biol Fil; 1977 Sep; 171(6):1209-16. PubMed ID: 148949
    [Abstract] [Full Text] [Related]

  • 13. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.
    Shu SY, Chou T, Sakai K.
    J Immunol; 1989 Jul 15; 143(2):740-8. PubMed ID: 2738408
    [Abstract] [Full Text] [Related]

  • 14. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
    Suda T, Fujiwara H, Mizushima Y, Shearer GM, Hamaoka T.
    J Natl Cancer Inst; 1986 Dec 15; 77(6):1267-72. PubMed ID: 2948049
    [Abstract] [Full Text] [Related]

  • 15. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L, McGowan P, Ashe S, Johnston JV, Hellström I, Hellström KE.
    Cancer Res; 1994 Oct 15; 54(20):5420-3. PubMed ID: 7522958
    [Abstract] [Full Text] [Related]

  • 16. Adoptive immunotherapy of newly induced murine sarcomas.
    Shu SY, Rosenberg SA.
    Cancer Res; 1985 Apr 15; 45(4):1657-62. PubMed ID: 3872168
    [Abstract] [Full Text] [Related]

  • 17. Conditions favouring the selection of either specific or non specific C. parvum-mediated, systemic antitumour immunity in mice.
    Scott MT.
    Dev Biol Stand; 1985 Apr 15; 38():273-6. PubMed ID: 415921
    [Abstract] [Full Text] [Related]

  • 18. Suppressed cellular immunity in mice harboring intraocular melanomas.
    Niederkorn JY.
    Invest Ophthalmol Vis Sci; 1984 Apr 15; 25(4):447-54. PubMed ID: 6608506
    [Abstract] [Full Text] [Related]

  • 19. Effect of Corynebacterium parvum on the immune response of the guinea pig to ovalbumin.
    Gauthier-Rahman S, Halpern B, Besluau D.
    Dev Biol Stand; 1984 Apr 15; 38():205-14. PubMed ID: 608508
    [No Abstract] [Full Text] [Related]

  • 20. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S, Fujiwara H, Yamane Y, Sano S, Nakajima H, Izumi Y, Arai H, Kawanishi Y, Tsuchida T, Hamaoka T.
    Jpn J Cancer Res; 1986 Feb 15; 77(2):182-9. PubMed ID: 3082830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.